These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
261 related articles for article (PubMed ID: 8163650)
1. Intimal hyperplasia after vascular injury is inhibited by antisense cdk 2 kinase oligonucleotides. Morishita R; Gibbons GH; Ellison KE; Nakajima M; von der Leyen H; Zhang L; Kaneda Y; Ogihara T; Dzau VJ J Clin Invest; 1994 Apr; 93(4):1458-64. PubMed ID: 8163650 [TBL] [Abstract][Full Text] [Related]
2. Single intraluminal delivery of antisense cdc2 kinase and proliferating-cell nuclear antigen oligonucleotides results in chronic inhibition of neointimal hyperplasia. Morishita R; Gibbons GH; Ellison KE; Nakajima M; Zhang L; Kaneda Y; Ogihara T; Dzau VJ Proc Natl Acad Sci U S A; 1993 Sep; 90(18):8474-8. PubMed ID: 8104336 [TBL] [Abstract][Full Text] [Related]
3. Suppression of neointimal smooth muscle cell accumulation in vivo by antisense cdc2 and cdk2 oligonucleotides in rat carotid artery. Abe J; Zhou W; Taguchi J; Takuwa N; Miki K; Okazaki H; Kurokawa K; Kumada M; Takuwa Y Biochem Biophys Res Commun; 1994 Jan; 198(1):16-24. PubMed ID: 8292019 [TBL] [Abstract][Full Text] [Related]
4. Pharmacokinetics of antisense oligodeoxyribonucleotides (cyclin B1 and CDC 2 kinase) in the vessel wall in vivo: enhanced therapeutic utility for restenosis by HVJ-liposome delivery. Morishita R; Gibbons GH; Kaneda Y; Ogihara T; Dzau VJ Gene; 1994 Nov; 149(1):13-9. PubMed ID: 7958977 [TBL] [Abstract][Full Text] [Related]
5. Prevention of graft coronary arteriosclerosis by antisense cdk2 kinase oligonucleotide. Suzuki J; Isobe M; Morishita R; Aoki M; Horie S; Okubo Y; Kaneda Y; Sawa Y; Matsuda H; Ogihara T; Sekiguchi M Nat Med; 1997 Aug; 3(8):900-3. PubMed ID: 9256282 [TBL] [Abstract][Full Text] [Related]
6. Intimal hyperplasia following vascular injury is not inhibited by an antisense thrombin receptor oligodeoxynucleotide. Herbert JM; Guy AF; Lamarche I; Mares AM; Savi P; Dol F J Cell Physiol; 1997 Feb; 170(2):106-14. PubMed ID: 9009139 [TBL] [Abstract][Full Text] [Related]
7. The effect of oligonucleotides to c-myb on vascular smooth muscle cell proliferation and neointima formation after porcine coronary angioplasty. Gunn J; Holt CM; Francis SE; Shepherd L; Grohmann M; Newman CM; Crossman DC; Cumberland DC Circ Res; 1997 Apr; 80(4):520-31. PubMed ID: 9118483 [TBL] [Abstract][Full Text] [Related]
9. Gene therapy for attenuating cardiac allograft arteriopathy using ex vivo E2F decoy transfection by HVJ-AVE-liposome method in mice and nonhuman primates. Kawauchi M; Suzuki J; Morishita R; Wada Y; Izawa A; Tomita N; Amano J; Kaneda Y; Ogihara T; Takamoto S; Isobe M Circ Res; 2000 Nov; 87(11):1063-8. PubMed ID: 11090553 [TBL] [Abstract][Full Text] [Related]
10. [The inhibitory effect of antisense phosphorothioate c-myc oligodeoxynucleotide on intimal hyperplasia in rat abdominal aortae after injury with a balloon catheter]. Wang J; Hu D; Liu K Zhonghua Yi Xue Za Zhi; 1998 May; 78(5):388-91. PubMed ID: 10923448 [TBL] [Abstract][Full Text] [Related]
11. Temporally and spatially coordinated expression of cell cycle regulatory factors after angioplasty. Wei GL; Krasinski K; Kearney M; Isner JM; Walsh K; Andrés V Circ Res; 1997 Mar; 80(3):418-26. PubMed ID: 9048663 [TBL] [Abstract][Full Text] [Related]
12. Downregulation of cyclin-dependent kinase 2 activity and cyclin A promoter activity in vascular smooth muscle cells by p27(KIP1), an inhibitor of neointima formation in the rat carotid artery. Chen D; Krasinski K; Sylvester A; Chen J; Nisen PD; Andrés V J Clin Invest; 1997 May; 99(10):2334-41. PubMed ID: 9153274 [TBL] [Abstract][Full Text] [Related]
13. An oligonucleotide decoy for transcription factor E2F inhibits mesangial cell proliferation in vitro. Tomita N; Horiuchi M; Tomita S; Gibbons GH; Kim JY; Baran D; Dzau VJ Am J Physiol; 1998 Aug; 275(2):F278-84. PubMed ID: 9691019 [TBL] [Abstract][Full Text] [Related]
14. Inhibition of vascular smooth muscle cell proliferation in vitro and in vivo by c-myc antisense oligodeoxynucleotides. Bennett MR; Anglin S; McEwan JR; Jagoe R; Newby AC; Evan GI J Clin Invest; 1994 Feb; 93(2):820-8. PubMed ID: 8113414 [TBL] [Abstract][Full Text] [Related]
15. Effect of phosphorothioated oligonucleotides on neointima formation in the rat carotid artery. Dissecting the mechanism of action. Bennett MR; Lindner V; DeBlois D; Reidy MA; Schwartz SM Arterioscler Thromb Vasc Biol; 1997 Nov; 17(11):2326-32. PubMed ID: 9409198 [TBL] [Abstract][Full Text] [Related]
16. Vascular smooth muscle cell proliferation is dependent upon upregulation of mitochondrial transcription factor A (mtTFA) expression in injured rat carotid artery. Yoshida T; Azuma H; Aihara K; Fujimura M; Akaike M; Mitsui T; Matsumoto T Atherosclerosis; 2005 Jan; 178(1):39-47. PubMed ID: 15585199 [TBL] [Abstract][Full Text] [Related]
17. Treatment of vascular smooth muscle cells with antisense phosphorothioate oligodeoxynucleotides directed against p42 and p44 mitogen-activated protein kinases abolishes DNA synthesis in response to platelet-derived growth factor. Robinson CJ; Scott PH; Allan AB; Jess T; Gould GW; Plevin R Biochem J; 1996 Nov; 320 ( Pt 1)(Pt 1):123-7. PubMed ID: 8947476 [TBL] [Abstract][Full Text] [Related]
18. Antisense proliferating cell nuclear antigen oligonucleotides inhibit intimal hyperplasia in a rat carotid artery injury model. Simons M; Edelman ER; Rosenberg RD J Clin Invest; 1994 Jun; 93(6):2351-6. PubMed ID: 7911126 [TBL] [Abstract][Full Text] [Related]
19. In vivo reduction of the nuclear factor-kappaB activity using synthetic cis-element decoy oligonucleotides suppresses intimal hyperplasia in the injured carotid arteries in rabbits. Takeuchi K; Itoh H; Yonemitsu Y; Matsumoto T; Kume M; Komori K; Maehara Y Surg Today; 2007; 37(7):575-83. PubMed ID: 17593477 [TBL] [Abstract][Full Text] [Related]
20. Inhibitory effect of fenofibrate on neointima hyperplasia via G(0)/G(1) arrest of cell proliferation. Lee JJ; Yu JY; Zhang WY; Kim TJ; Lim Y; Kwon JS; Kim DW; Myung CS; Yun YP Eur J Pharmacol; 2011 Jan; 650(1):342-9. PubMed ID: 21040719 [TBL] [Abstract][Full Text] [Related] [Next] [New Search]